Iradimed Corp (IRMD)
NASDAQ:IRMD
Holding IRMD?
Track your performance easily

Iradimed (IRMD) Financial Statements

148 Followers

Iradimed Financial Overview

Iradimed's market cap is currently ―. The company's EPS TTM is $1.46; its P/E ratio is 39.28; and it has a dividend yield of 0.80%. Iradimed is scheduled to report earnings on February 6, 2025, and the estimated EPS forecast is $0.43. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 18.33M$ 17.93M$ 17.60M$ 17.45M$ 16.50M
Gross Profit$ 14.19M$ 14.01M$ 13.39M$ 13.41M$ 12.84M
EBIT$ 6.42M$ 6.27M$ 5.24M$ 5.16M$ 6.41M
EBITDA$ 6.62M$ 6.47M$ 5.47M$ 5.37M$ 6.60M
Net Income Common Stockholders$ 5.05M$ 4.90M$ 4.14M$ 4.54M$ 5.07M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 51.72M$ 48.54M$ 45.13M$ 49.76M$ 46.75M
Total Assets$ 94.25M$ 89.95M$ 88.01M$ 92.16M$ 87.41M
Total Debt$ 264.07K$ 371.85K$ 1.94M$ 2.04M$ 2.15M
Net Debt$ -51.46M$ -48.16M$ -43.19M$ -47.72M$ -44.60M
Total Liabilities$ 10.81M$ 10.28M$ 11.89M$ 20.74M$ 12.84M
Stockholders Equity$ 83.43M$ 79.67M$ 76.12M$ 71.42M$ 74.57M
Cash Flow-
Free Cash Flow$ 5.10M$ 5.37M$ 3.40M$ 3.28M$ 953.66K
Operating Cash Flow$ 9.12M$ 6.64M$ 3.88M$ 3.91M$ 1.39M
Investing Cash Flow$ -4.01M$ -1.27M$ -478.80K$ -632.82K$ -439.02K
Financing Cash Flow$ -1.92M$ -1.96M$ -8.04M$ -262.59K$ -31.37K
Currency in USD

Iradimed Earnings and Revenue History

Iradimed Debt to Assets

Iradimed Cash Flow

Iradimed Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis